The 36-Patient Acne Laser Pilot Published in 2026: What Researchers Still Need to Learn for Adults With Persistent Acne

The 2026 pilot tested three light-based treatments in 36 people with moderate-to-severe inflammatory acne and found improvement in every group, with no device winning. For adults with persistent acne — acne that begins or continues in adulthood — researchers still need larger, longer trials before these results can change routine care.

According to the U.S. National Library of Medicine, the study assigned patients to pulsed dye laser, intense pulsed light, or Q-switched Nd:YAG 1064-nm laser for three sessions spaced two weeks apart, as described in the July 2026 pilot record. Lesion counts and severity scores fell during treatment, and daily-life impact improved.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

What did the pilot test?
Did one device work better?
How did daily life and comfort compare?
Why can't this pilot settle adult treatment?
What should adults ask before considering laser?

What did the pilot test?

Researchers enrolled 36 patients with moderate-to-severe inflammatory acne. Inflammatory acne means red bumps, tender lumps, and pus-filled spots, not only blackheads.

Each group received three treatments at two-week intervals. The three approaches were pulsed dye laser, intense pulsed light, and Q-switched Nd:YAG 1064-nm laser. Final checks occurred two weeks after the third session.

Did one device work better?

Lesion counts and severity scores decreased significantly within each group during treatment. The difference matters for readers comparing devices because improvement happened with all three options.

No significant difference emerged between the three groups at any session, with P-values from 0.06 to 0.92, according to the U.S. National Library of Medicine in the July 2026 pilot record. A P-value above 0.05 usually means the gap could be due to chance.

How did daily life and comfort compare?

Acne-related disability fell significantly from baseline to two weeks after the third session in all groups. The tool was the Cardiff Acne Disability Index, a short questionnaire about how acne affects daily activities and feelings.

There was no significant between-group difference on that score at P=0.45. Side effects were minimal, with mild redness in one pulsed-dye-laser participant, while Q-switched Nd:YAG participants reported less procedural pain than the other two groups.

Why can't this pilot settle adult treatment?

The trial was small and short, with about 12 patients per arm and follow-up only two weeks after the last treatment. It cannot establish durability, recurrence, scarring, or effects in adult subgroups.

That gap matters because adult persistence is common. The American Academy of Dermatology notes that acne affects 85% of adolescents and often begins or continues in adulthood, especially in women, as reported in the Academy's updated acne guidelines report. Larger trials need longer follow-up, more adults, and measures of relapse and scars.

What should adults ask before considering laser?

The American Academy of Dermatology's 2024 acne guidelines found evidence insufficient to recommend laser and light-based devices, so clinicians should treat these 36-patient results as exploratory rather than standard care. An appointment can still be useful for reviewing proven options and personal fit.

Ask what diagnosis and severity you have and what else could explain breakouts
Ask which first-line treatments fit your history, pregnancy plans, and skin tone
Ask about expected benefits, number of visits, cost, aftercare, and pain
Ask how results will be tracked and when to change course